THÔNG TIN TÀI LIỆU
flutter Br Heart J 1980;44(5):602–603 254 Kirklin JW, Ellis FH Jr Surgical relief of diffuse subvalvular aortic stenosis Circulation 1961;24:739–742 255 Altarabsheh SE, Dearani JA, Burkhart HM, et al Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults Ann Thorac Surg 2013;95(2):663–669 [discussion 669] 256 Maron BJ, Nishimura RA, McKenna WJ, et al Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy A randomized, double-blind, crossover study (M-PATHY) Circulation 1999;99(22):2927–2933 257 Nishimura RA, Trusty JM, Hayes DL, et al Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial J Am Coll Cardiol 1997;29(2):435–441 258 Maron BJ, Nishimura RA Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014 Circulation 2014;130(18):1617–1624 259 Maron BJ, Shen WK, Link MS, et al Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 2000;342(6):365–373 260 Maron BJ, Maron MS, Semsarian C Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors Heart Rhythm 2012;9(1):57–63 261 Rowin EJ, Maron BJ, Haas TS, et al Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management J Am Coll Cardiol 2017;69(7):761–773 262 Maron BJ, Casey SA, Chan RH, et al Independent assessment of the European society of cardiology sudden death risk model for hypertrophic cardiomyopathy Am J Cardiol 2015;116(5):757–764 263 Lambiase PD, Gold MR, Hood M, et al Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts Heart Rhythm 2016;13(5):1066–1074 264 Axelsson A, Iversen K, Vejlstrup N, et al Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial Lancet Diabetes Endocrinol 2015;3(2):123–131 265 Saberi S, Wheeler M, Bragg-Gresham J, et al Effect of Moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: A randomized clinical trial JAMA 2017;317(13):1349–1357 266 Towbin JA, Lowe AM, Colan SD, et al Incidence, causes, and outcomes of dilated cardiomyopathy in children JAMA 2006;296(15):1867–1876 267 Nugent AW, Daubeney PE, Chondros P, et al The epidemiology of childhood cardiomyopathy in Australia N Engl J Med 2003;348(17):1639– 1646 268 Lipshultz SE, Sleeper LA, Towbin JA, et al The incidence of pediatric cardiomyopathy in two regions of the United States N Engl J Med 2003;348(17):1647–1655 269 Arola A, Jokinen E, Ruuskanen O, et al Epidemiology of idiopathic cardiomyopathies in children and adolescents A nationwide study in Finland Am J Epidemiol 1997;146(5):385–393 270 Andrews RE, Fenton MJ, Ridout DA, Burch M British congenital cardiac A New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and ... 2017;69(7):761–773 262 Maron BJ, Casey SA, Chan RH, et al Independent assessment of the European society of cardiology sudden death risk model for hypertrophic cardiomyopathy Am J Cardiol 2015;116(5):757–764... N Engl J Med 2003;348(17):1639– 1646 268 Lipshultz SE, Sleeper LA, Towbin JA, et al The incidence of pediatric cardiomyopathy in two regions of the United States N Engl J Med 2003;348(17):1647–1655
Ngày đăng: 22/10/2022, 12:50
Xem thêm: